"UChicago Medicine - Orland Park offers quick and convenient specialty and primary care in a state-of-the-art outpatient center. Conveniently located at 143rd Street & South La Grange Road, our outpatient clinic has a robust offering of primary care services as well as specialty care for people who need help managing chronic illnesses. We have easy-to-use self check-in kiosks, same-day appointments (for certain specialties and primary care), online scheduling, extended and weekend hours, lab services, radiology and X-rays, infusion care and an on-site CVS pharmacy."

During the past decade, University of Chicago Medicine-Orland Park conducted 92 clinical trials. In the 10-year time frame, 92 clinical trials started and 17 clinical trials were completed, i.e. on average, 18.5% percent of trials that started reached the finish line to date. In the past 5 years, 43 clinical trials started and 17 clinical trials were completed. i.e. 39.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Chicago Medicine-Orland Park" #1 sponsor was "National Cancer Institute (NCI)" with 50 trials, followed by "SWOG Cancer Research Network" with 13 trials sponsored, "Alliance for Clinical Trials in Oncology" with 12 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored and "NRG Oncology" with 6 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Chicago Medicine-Orland Park" #1 collaborator was "National Cancer Institute (NCI)" with 38 trials as a collaborator, "NRG Oncology" with 8 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator and "Ono Pharmaceutical Co. Ltd" with 2 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "University of Chicago Medicine-Orland Park" are "Recurrent Ovarian Carcinoma" (6 trials), "Invasive Breast Carcinoma" (5 trials), "Stage II Breast Cancer" (5 trials), "Stage IV Renal Cell Cancer AJCC v8" (5 trials) and "Malignant Solid Neoplasm" (4 trials). Many other conditions were trialed in "University of Chicago Medicine-Orland Park" in a lesser frequency.

Most popular intervention types in "University of Chicago Medicine-Orland Park" are "Drug" (75 trials), "Other" (54 trials), "Biological" (42 trials), "Procedure" (39 trials) and "Radiation" (11 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (25 trials), "Computed Tomography" (23 trials), "Biospecimen Collection" (22 trials), "Laboratory Biomarker Analysis" (21 trials) and "Questionnaire Administration" (21 trials). Other intervention names were less common.

The vast majority of trials in "University of Chicago Medicine-Orland Park" are 79 trials for "All" genders, 15 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "University of Chicago Medicine-Orland Park". undefined are not yet recruiting, 34 are recruiting, 46 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in University of Chicago Medicine-Orland Park, 7 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Chicago Medicine-Orland Park, 7 "Phase 1" clinical trials were conducted, 53 "Phase 2" clinical trials and 41 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".